| scholarly article | Q13442814 |
| P356 | DOI | 10.1111/J.1440-1681.2007.04794.X |
| P698 | PubMed publication ID | 17892505 |
| P50 | author | Philip Eaton | Q55875744 |
| P2093 | author name string | Michael J Shattock | |
| James R Bell | |||
| P2860 | cites work | A MAP kinase targeted by endotoxin and hyperosmolarity in mammalian cells | Q28237789 |
| Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium | Q28304462 | ||
| Inhibition of p38 mitogen-activated protein kinase decreases cardiomyocyte apoptosis and improves cardiac function after myocardial ischemia and reperfusion | Q33857696 | ||
| Signal transduction of ischemic preconditioning | Q34421605 | ||
| MAP kinases in the immune response | Q34542231 | ||
| Direct measurement of free radical generation following reperfusion of ischemic myocardium | Q34602572 | ||
| Multidisciplinary utilization of dimethyl sulfoxide: pharmacological, cellular, and molecular aspects | Q35093892 | ||
| Cardiac pharmacology of dimethyl sulfoxide and its postulated relevance to organ preservation in ischemic or hypoxic states | Q40136501 | ||
| The pyridinyl imidazole inhibitor SB203580 blocks phosphoinositide-dependent protein kinase activity, protein kinase B phosphorylation, and retinoblastoma hyperphosphorylation in interleukin-2-stimulated T cells independently of p38 mitogen-activate | Q40897138 | ||
| Stimulation of the stress-activated mitogen-activated protein kinase subfamilies in perfused heart. p38/RK mitogen-activated protein kinases and c-Jun N-terminal kinases are activated by ischemia/reperfusion | Q41074846 | ||
| An inhibitor of p38 mitogen-activated protein kinase protects neonatal cardiac myocytes from ischemia | Q41609637 | ||
| Stress-activated protein kinases: activation, regulation and function. | Q41647879 | ||
| alpha B-crystallin gene induction and phosphorylation by MKK6-activated p38. A potential role for alpha B-crystallin as a target of the p38 branch of the cardiac stress response | Q41736665 | ||
| Translocation of PKC, protein phosphatase inhibition and preconditioning of rabbit cardiomyocytes | Q42524447 | ||
| Pyridinyl imidazole inhibitors of p38 mitogen-activated protein kinase bind in the ATP site | Q42550034 | ||
| p38 MAPK activity is not increased early during sustained coronary artery occlusion in preconditioned versus control rabbit heart | Q43556242 | ||
| Failure to precondition pathological human myocardium | Q43788569 | ||
| Ischemic preconditioning in the intact rat heart is mediated by delta1- but not mu- or kappa-opioid receptors | Q44348474 | ||
| Marked reduction in myocardial infarct size due to prolonged infusion of an antioxidant during reperfusion | Q47377016 | ||
| Protection against infarction afforded by preconditioning is mediated by A1 adenosine receptors in rabbit heart | Q47638553 | ||
| Activation of mitogen-activated protein kinases and activator protein-1 in myocardial infarction in rats | Q47767276 | ||
| The p38 MAPK inhibitor, SB203580, abrogates ischaemic preconditioning in rat heart but timing of administration is critical. | Q50506897 | ||
| Role of phasic dynamism of p38 mitogen-activated protein kinase activation in ischemic preconditioning of the canine heart. | Q53898831 | ||
| P433 | issue | 2 | |
| P304 | page(s) | 126-134 | |
| P577 | publication date | 2007-09-24 | |
| P1433 | published in | Clinical and Experimental Pharmacology and Physiology | Q5133807 |
| P1476 | title | Role of p38-mitogen-activated protein kinase in ischaemic preconditioning in rat heart | |
| P478 | volume | 35 |
| Q43004985 | A cardiopulmonary bypass with deep hypothermic circulatory arrest rat model for the investigation of the systemic inflammation response and induced organ damage. |
| Q38749984 | Complement-induced activation of MAPKs and Akt during sepsis: role in cardiac dysfunction |
| Q34289211 | Crosstalk between mitogen-activated protein kinases and mitochondria in cardiac diseases: therapeutic perspectives |
| Q28296128 | Mitogen-activated protein kinase signaling in the heart: angels versus demons in a heart-breaking tale |
| Q33678033 | Protein Kinases as Drug Development Targets for Heart Disease Therapy |
| Q58290942 | SIRT1 modulates MAPK pathways in ischemic–reperfused cardiomyocytes |
| Q92491742 | Sevoflurane Pre-conditioning Ameliorates Diabetic Myocardial Ischemia/Reperfusion Injury Via Differential Regulation of p38 and ERK |
| Q33613072 | The differential effects of FTY720 on functional recovery and infarct size following myocardial ischaemia/reperfusion |
| Q46775215 | The intrinsic resistance of female hearts to an ischemic insult is abrogated in primary cardiac hypertrophy |
| Q36701541 | Tumor Necrosis Factor-α: Life and Death of Hepatocytes During Liver Ischemia/Reperfusion Injury |
Search more.